Use of ketamine and esketamine for depression: an overview of systematic reviews with meta-analyses

[1] Brigitta B(2002)Pathophysiology of depression and mechanisms of treatment Dialogues Clin Neurosci 4 7-20

[2] Hasler G(2010)Pathophysiology of depression: do we have any solid evidence of interest to clinicians? World Psychiatry 9 155-161

[3] Greenberg PE(2015)The economic burden of adults with major depressive disorder in the United States (2005 and 2010) J Clin Psychiatry 76 155-162

[4] Fournier AA(2013)Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile BMC Med 11 129-S50

[5] Sisitsky T(2017)Clinical practice guidelines for the management of depression Indian J Psychiatry 59 S34-41

[6] Pike CT(2010)The timing of antidepressant effects: a comparison of diverse pharmacological and somatic treatments Pharmaceuticals (Basel) 3 19-354

[7] Kessler RC(2000)Antidepressant effects of ketamine in depressed patients Biol Psychiatry 47 351-1215

[8] Penninx BW(2018)Attenuation of antidepressant effects of ketamine by opioid receptor antagonism Am J Psychiatry 175 1205-794

[9] Milaneschi Y(2017)Considerations on the off-label use of ketamine as a treatment for mood disorders JAMA 318 793-35

[10] Lamers F(2021)Intranasal esketamine: from origins to future implications in treatment-resistant depression J Psychiatr Res 137 29-12

[1] Brigitta B(2002)Pathophysiology of depression and mechanisms of treatment Dialogues Clin Neurosci 4 7-20

[2] Hasler G(2010)Pathophysiology of depression: do we have any solid evidence of interest to clinicians? World Psychiatry 9 155-161

[3] Greenberg PE(2015)The economic burden of adults with major depressive disorder in the United States (2005 and 2010) J Clin Psychiatry 76 155-162

[4] Fournier AA(2013)Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile BMC Med 11 129-S50

[5] Sisitsky T(2017)Clinical practice guidelines for the management of depression Indian J Psychiatry 59 S34-41

[6] Pike CT(2010)The timing of antidepressant effects: a comparison of diverse pharmacological and somatic treatments Pharmaceuticals (Basel) 3 19-354

[7] Kessler RC(2000)Antidepressant effects of ketamine in depressed patients Biol Psychiatry 47 351-1215

[8] Penninx BW(2018)Attenuation of antidepressant effects of ketamine by opioid receptor antagonism Am J Psychiatry 175 1205-794

[9] Milaneschi Y(2017)Considerations on the off-label use of ketamine as a treatment for mood disorders JAMA 318 793-35

[10] Lamers F(2021)Intranasal esketamine: from origins to future implications in treatment-resistant depression J Psychiatr Res 137 29-12